Potent matrix metalloproteinase inhibitors: Amino-carboxylate compounds containing modifications of the P1 residue

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 4, 1996, Pages 379-384

  Xue, Chu Biao ^a   He, Xiaohua ^a   Roderick, John ^a   DeGrado, William F ^a   Decicco, Carl ^a   Copeland, Robert A ^a  

^a DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; MATRIX METALLOPROTEINASE; STROMELYSIN;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME BINDING; ENZYME INHIBITION; STRUCTURE ACTIVITY RELATION;

EID: 0029880203     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00028-5     Document Type: Article

References (18)

1. Woessner, J. F. FASEB J. 1991, 5, 2145-2154.
2. Walakovits, L. A.; Bhardwaj, N.; Gallick, G. S.; Lark, M. W. Arthritis Rheum. 1992, 35, 35-42.
3. Gravallese, E. M.; Darling, J. M.; Ladd, A. L.; Katz, J. N.; Glimcher, L. H.; Arthritis Rheum. 1991, 34, 1076-1084.
4. Okada, Y.; Shinmei, M.; Tanaka, O.; Naka, K.; Kimura, A.; Nakanishi, I.; Bayliss, M. T.; Iwata, K.; Nagase, H. Lab. Invest. 1992, 66, 680-690.
5. Johnson, W. H.; Roberts, N. A.; Borkakoti, N. J. Enzyme Inhib. 1987, 2, 1-22.
6. Wahl, R. C.; Dunlap, R. P.; Morgan, B. A. Annu. Rep. Med. Chem. 1990, 25, 177-184.
7. Henderson, B.; Docherty, A. J. P.; Beeley, N. R. A. Drugs Future, 1990, 15, 495-508.
8. Beeley, N. R. A.; Ansell, P. R. J.; Docherty, A. J. P. Curr. Opin. Ther. Patents, 1994, 4, 7-16.
9. Schwartz, M. A.; VanWart, H. E. In Progress in Medicinal Chemistry: Vol. 29; Ellis, G. P., Luscomb, D. K., Eds.; Elsevier Science Publishers: London, 1992.
10. Angiotensin Converting Enzyme Inhibitors. Kostis, J. B., DeFelice, E. A., Eds.; Alan R. Liss Inc.: New York, 1987.
11. Chapman, K. T.; Kopka, I. E.; Durette, P. L.; Esser, C. K.; Lanza, T. J.; Izquierdo-Martin, M.; Niedzwiecki, L.; Chang, B.; Harrison, R. K.; Kuo, D. W.; Lin, T.-Y.; Stein, R. L.; Hagmann, W. K. J. Med. Chem. 1993, 36, 4293-4301.
12. Brown, F. K.; Brown, P. J.; Bickett, D. M.; Chambers, C. L.; Davies, H. G.; Deaton, D. N.; Drewry, D.; Foley, M. McElroy, A. B.; Gregson, M.; McGeehan, G. M.; Myers, P. L.; Norton, D.; Salovich, J. M.; Schoenen, F. J.; Ward, P. J. Med. Chem. 1994, 37, 674-688.
13. Xue, C.-B.; DeGrado, W. F. Tetrahedron Lett. 1995, 36, 55-58.
14. Castro, B.; Dormoy, J. R.; Evin, G.; Selve, C. Tetrahedron Lett. 1975, 1219.
15. Hardman, K. unpublished results.
16. Copeland, R. A.; Lomlardo, D.; Giannaras, J.; Decicco, C. P. Bioorg. Med. Chem. Lett. 1995, 5, 1947-1952.
17. Broadhurst, M. J.; Brown, P. A.; Johnson, W. H.; Lawton, G. European Patent 574,758, December 22, 1993.
18. Related work disclosing the importance of the backbone amide bonds was presented at the Inflammation Research Association 7th International Conference, Mt. Laurel Resort, Pennsylvania, September 25, 1994 by the Merck group (Kopka I. E. et al).